USPTO serial 79031658
MICROMET
Reviewed by CopyMark Law Group
Reg. 3356628Status 404
- Filing date
- Status date
- Registration date
- Dec 18, 2007
- Examiner
- STRUCK, ROBERT J
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with MICROMET?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
L. Alison Davis
Steven L. Highlander Fulbright & Jaworski L.L.P.98 San Jacinto Blvd., Suite 1100Austin, TX 78701UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical preparations for scientific purposes excluding chemical preparations for the treatment of water; chemical agents for characterizing and examination of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides; biochemical preparations, namely, eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides for scientific purposes | SECTION 71 - CANCELLED | — |
| 005 | Medicines for the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; pharmaceutical and veterinary preparations for the treatment of cancer, tumorous diseases, proliferative diseases, allergies, auto-immune diseases, inflammation, inflammatory diseases, infectious diseases, osteoporosis, graft versus host and host versus graft diseases, transplant rejection, coronary heart diseases, and minimal residual diseases, restenosis, metabolic disorders, neurological disorders, diabetes, B cell malignancy, rheumatoid arthritis, immunological disorders, parasitic reactions, skin diseases, neurodegenerative diseases; preparations for diagnosis and analysis of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines and animal and human material for medical or veterinary purposes; biological preparations in the nature of eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides for medical purposes; sanitary preparations for medical purposes, particularly agents for dental care | SECTION 71 - CANCELLED | — |
| 042 | Scientific and industrial research, particularly in the field of molecular biology, biotechnology, genetics, medicine, pharmacology and cell biology; identification of target structures for the development of medicaments, identifications of cell growth and differentiation; determination of the pathogenesis of animal and human diseases; development of medicaments; developments of technologies and means for scientific and industrial research, particularly of eukaryotic cells, eukaryotic cell culture lines, animal and human material, nucleic acids and polypeptides; providing of technology, namely, technology consultation, for scientific and industrial research; performance of chemical, biological and scientific diagnoses and analyses of animal and human diseases, eukaryotic cells, eukaryotic cell culture lines, animal and human material, microorganisms, nucleic acids and polypeptides for scientific purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Micromet AG
- Other trademarks owned by Micromet AG
- Other trademarks owned by Micromet AG
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named MICROMET
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 7, 2021 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Aug 7, 2021 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Aug 7, 2015 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jul 16, 2015 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jul 16, 2015 | INPC | INVALIDATION PROCESSED | — |
| Mar 25, 2015 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jul 25, 2014 | C71T | CANCELLED SECTION 71 | — |
| Jun 18, 2011 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 3, 2009 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 8, 2008 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 8, 2008 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 24, 2008 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 18, 2007 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 2, 2007 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 12, 2007 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 5, 2007 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 28, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 28, 2007 | ALIE | ASSIGNED TO LIE | — |
| Jul 17, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 10, 2007 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jul 9, 2007 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2007 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 25, 2007 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 25, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 25, 2007 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 18, 2007 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 3, 2007 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 3, 2007 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 22, 2006 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 21, 2006 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2006 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2006 | NWAP | NEW APPLICATION ENTERED | — |
| Dec 14, 2006 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |